Shareholding disclosure

Kenneth C. Griffin

Declared position

Threshold

Fell below threshold

Timeline

Published

22.09.2021

Transaction

16.09.2021

Voting rights breakdown

Voting rights acquired0%

Voting rights sold0%

Below threshold3%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAL9K00058

Beneficial owner

Kenneth C. Griffin

Declared address

Kenneth C. Griffin, Chicago, IL

Citadel Securities Financial Trading (Ireland) Designated Activity Company, Dublin, Ireland

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Kenneth C. Griffin

Basilea Pharmaceutica AG, Allschwil22.09.2021TAL9K00058

Disclosure summary

Kenneth C. Griffin disclosed a holding in Basilea Pharmaceutica AG, Allschwil that fell below the publication threshold, published by SIX Exchange Regulation on 22.09.2021, at 3% of voting rights. Notice category: Single shareholder.

Disclosed position

Below threshold

Voting rights acquired0%

Voting rights sold0%

Below threshold3%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Kenneth C. Griffin disclosed a holding in Basilea Pharmaceutica AG, Allschwil, published on 22.09.2021.

Publication date22.09.2021

Transaction date16.09.2021

Issuing companyBasilea Pharmaceutica AG, Allschwil

Beneficial ownerKenneth C. Griffin

Declared addressKenneth C. Griffin, Chicago, IL

CategorySingle shareholder

Voting rights acquired0%

Voting rights sold0%

Below threshold3%

ExchangeXSWX

Notification IDTAL9K00058

Conditions

Citadel Securities Financial Trading (Ireland) Designated Activity Company, Dublin, Ireland

Source: SIX Exchange Regulation · Publication date: 22.09.2021

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open